RobustoMed

RobustoMed is a wholly owned subsidiary of Enzolytics focused on business development and international partnership activities for medical development-stage drug and product companies. Public disclosures describe the subsidiary as based in Atlanta, Georgia and intended to expand revenue and partnerships in international markets, including Brazil, Costa Rica, and other emerging markets. Available information does not indicate that RobustoMed independently operates a disclosed therapeutic pipeline or proprietary R&D platform separate from its parent. Instead, it appears to function primarily as a strategic and commercial vehicle within the broader Enzolytics organization.